BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 28712700)

  • 1. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
    Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
    Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.
    Aghaei F; Tan M; Hollingsworth AB; Zheng B
    J Magn Reson Imaging; 2016 Nov; 44(5):1099-1106. PubMed ID: 27080203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapy.
    Aghaei F; Tan M; Hollingsworth AB; Qian W; Liu H; Zheng B
    Med Phys; 2015 Nov; 42(11):6520-8. PubMed ID: 26520742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
    Fan M; Li H; Wang S; Zheng B; Zhang J; Li L
    PLoS One; 2017; 12(2):e0171683. PubMed ID: 28166261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
    Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
    Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
    Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
    Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
    NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
    Zhang X; Teng X; Zhang J; Lai Q; Cai J
    Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI.
    Lee SH; Kim JH; Cho N; Park JS; Yang Z; Jung YS; Moon WK
    Med Phys; 2010 Aug; 37(8):3940-56. PubMed ID: 20879557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
    Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
    J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations.
    Yang Q; Li L; Zhang J; Shao G; Zheng B
    Med Phys; 2015 Jan; 42(1):103-9. PubMed ID: 25563251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
    El Adoui M; Drisis S; Benjelloun M
    Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
    Wang J; Kato F; Oyama-Manabe N; Li R; Cui Y; Tha KK; Yamashita H; Kudo K; Shirato H
    PLoS One; 2015; 10(11):e0143308. PubMed ID: 26600392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
    Guo W; Zhang Y; Luo D; Yuan H
    Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
    Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
    Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.